Moolec Science (MLEC) FCF Margin (2023 - 2024)
Moolec Science's (MLEC) quarterly FCF Margin came in at 72.99% in Q4 2024, down 80869.0% year-on-year from N/an in Q1 2024, and up 206.56% quarter-over-quarter from 68.49% in Q3 2024.
Moolec Science (MLEC) FCF Margin (2023 - 2024) Analysis & Trends
Moolec Science has disclosed FCF Margin across 2 years of filings, most recently posting 72.99% for Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -3.98% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 43.35% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Moolec Science | 6.98 Bn | 6.98 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 72.99% |
| Sep 30, 2024 | -68.49% |
| Mar 31, 2024 | -123.70% |
| Dec 31, 2023 | 881.68% |
| Sep 30, 2023 | -94.20% |